Telefon:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antikoerper-online.de

STK33 Produkte

(serine/threonine Kinase 33 (STK33))

Kategorien

Serine/threonine protein kinase which phosphorylates VIME.

antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.

Ausgewählte STK33 Kategorien

STK33 Antikörper

High quality antibodies with extensive validation data.

STK33 Proteine

Proteins for various applications incl. WB, ELISA, IF etc.

Empfohlene STK33 Antikörper

Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität Human
Applikation IF, IP, RNAi, ELISA, WB
Validierungen
  • (1)
  • collections(7)
Kat. Nr. ABIN566310
Menge 100 μg
Reaktivität Human
Applikation IF, IP, ELISA, WB
Validierungen
  • (2)
  • collections(8)
Kat. Nr. ABIN566314
Menge 100 μg
Reaktivität Human
Applikation IP, ELISA, WB
Validierungen
  • (2)
  • collections(5)
Kat. Nr. ABIN566312
Menge 50 μg

Empfohlene STK33 ELISA Kits

Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität Human
Analytical Method Quantitative Sandwich ELISA
Validierungen
Kat. Nr. ABIN6232490
Menge 96 tests

Empfohlene STK33 Proteine

Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität Human
Source Wheat germ
Validierungen
  • collections(2)
Kat. Nr. ABIN1321694
Menge 10 μg
Reaktivität Human
Source Insect Cells
Validierungen
  • collections(2)
Kat. Nr. ABIN5570568
Menge 5 μg
Reaktivität Human
Source Insect Cells
Validierungen
  • collections(1)
Kat. Nr. ABIN3073473
Menge 1 mg

Neueste Publikationen zu unseren STK33 Produkten

Azoitei, Hoffmann, Ellegast, Ball, Obermayer, Gößele, Koch, Faber, Genze, Schrader, Kestler, Döhner, Chiosis, Glimm, Fröhling, Scholl: "Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33." in: The Journal of experimental medicine, Vol. 209, Issue 4, pp. 697-711, (2012) (PubMed).

Babij, Zhang, Kurzeja, Munzli, Shehabeldin, Fernando, Quon, Kassner, Ruefli-Brasse, Watson, Fajardo, Jackson, Zondlo, Sun, Ellison, Plewa, San, Robinson, McCarter, Schwandner, Judd, Carnahan, Dussault: "STK33 kinase activity is nonessential in KRAS-dependent cancer cells." in: Cancer research, Vol. 71, Issue 17, pp. 5818-26, (2011) (PubMed).

Scholl, Fröhling, Dunn, Schinzel, Barbie, Kim, Silver, Tamayo, Wadlow, Ramaswamy, Döhner, Bullinger, Sandy, Boehm, Root, Jacks, Hahn, Gilliland: "Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells." in: Cell, Vol. 137, Issue 5, pp. 821-34, (2009) (PubMed).

Cantrell: "Phosphoinositide 3-kinase signalling pathways." in: Journal of cell science, Vol. 114, Issue Pt 8, pp. 1439-45, (2001) (PubMed).

Blume-Jensen, Hunter: "Oncogenic kinase signalling." in: Nature, Vol. 411, Issue 6835, pp. 355-65, (2001) (PubMed).

Jhiang: "The RET proto-oncogene in human cancers." in: Oncogene, Vol. 19, Issue 49, pp. 5590-7, (2000) (PubMed).

Synonyme und alternative Namen zu STK33

serine/threonine kinase 33 (STK33), serine/threonine kinase 33 (Stk33), 4921505G21Rik, AW061264

Bezeichner auf Proteinebene für STK33

  • serine/threonine-protein kinase 33
Sie sind hier:
help Kundenservice